Mergers & Acquisitions (M&A) in USA

Mergers and acquisitions in the USA represent one of the most legally demanding transaction environments in the world. A buyer or seller who enters the US market without understanding its regulatory architecture, deal mechanics and litigation exposure risks significant financial and reputational loss. The US M&A framework combines federal securities law, state corporate law - primarily Delaware - antitrust regulation and sector-specific oversight, creating a multi-layered system that rewards preparation and punishes shortcuts. This article explains the core legal tools available to international and domestic parties, the procedural sequence from letter of intent to closing, the risks that surface after signing, and the strategic choices that determine whether a transaction delivers its intended value.

The United States does not have a single federal M&A statute. Instead, transactions are governed by an interlocking set of laws at both federal and state levels. The Delaware General Corporation Law (DGCL) is the most influential state statute, governing the internal affairs of the majority of US public and private companies. Section 251 of the DGCL governs statutory mergers, while Section 271 covers asset sales requiring shareholder approval. For public companies, the Securities Exchange Act of 1934 - particularly Sections 13(d) and 14(d) - regulates tender offers and beneficial ownership disclosure. The Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) requires pre-merger notification to the Federal Trade Commission (FTC) and the Department of Justice (DOJ) for transactions above specified thresholds.

State law governs fiduciary duties of directors and officers. Delaware courts - particularly the Court of Chancery - have developed a sophisticated body of case law on the duty of care and the duty of loyalty. The business judgment rule protects directors who act on an informed basis in good faith, but transactions involving controlling shareholders or conflicts of interest attract heightened scrutiny under the entire fairness standard. International buyers frequently underestimate the significance of these fiduciary standards, assuming that a board approval is sufficient to insulate a deal from challenge. In practice, a transaction that lacks a proper market check or independent committee process remains vulnerable to post-closing litigation.

For regulated industries - banking, insurance, telecommunications, defence contracting and healthcare - additional federal and state approvals are required. The Committee on Foreign Investment in the United States (CFIUS) reviews acquisitions by foreign persons that could affect national security. CFIUS jurisdiction has expanded significantly under the Foreign Investment Risk Review Modernization Act of 2018 (FIRRMA), covering not only controlling investments but also certain non-controlling minority stakes in critical technology, critical infrastructure and sensitive personal data businesses. A non-obvious risk for international acquirers is that CFIUS review can be triggered even where the buyer does not seek operational control.

Three primary structures govern US M&A transactions, and the choice between them carries material legal, tax and operational consequences.

A share deal (stock purchase) transfers ownership of the target entity by acquiring its equity. The buyer steps into the shoes of the seller and inherits all liabilities - disclosed and undisclosed - of the target. This structure is simpler from an operational continuity standpoint: contracts, licences and permits typically remain in place without third-party consent. However, the liability exposure is comprehensive. Representations and warranties insurance (RWI) has become a standard tool in US private M&A to bridge the gap between buyer's desire for indemnification and seller's desire for a clean exit.

An asset deal transfers specific assets and liabilities rather than the entity itself. The buyer selects which assets to acquire and which liabilities to assume, providing greater protection against unknown obligations. Asset deals are more common in distressed transactions, carve-outs and situations where the target carries significant contingent liabilities such as environmental claims or product liability exposure. The administrative burden is higher: contracts must be assigned, licences re-applied for, and employees formally rehired. Tax treatment also differs - asset deals generally allow the buyer to step up the tax basis of acquired assets, which can generate significant depreciation benefits under the Internal Revenue Code (IRC) Section 338 election framework.

A statutory merger under DGCL Section 251 combines two entities by operation of law, with one surviving. Shareholders of the disappearing entity receive consideration - cash, stock or a combination - and dissenting shareholders may exercise appraisal rights under DGCL Section 262, entitling them to judicial determination of fair value. Appraisal litigation has become a meaningful risk in Delaware transactions, particularly where the deal price is perceived as inadequate by arbitrageurs who acquire shares specifically to pursue appraisal claims.

A joint venture (JV) is not a merger but deserves mention as a structural alternative. A US joint venture - typically structured as a Delaware LLC or C-corporation - allows parties to combine specific assets or operations without a full acquisition. JV agreements must address governance, deadlock resolution, exit mechanisms and intellectual property ownership with precision. Poorly drafted JV agreements are a frequent source of commercial litigation in US courts.

To receive a checklist on selecting the right M&A deal structure for transactions in the USA, send a request to info@vlolawfirm.com.

Due diligence is the investigative process by which a buyer assesses the legal, financial, operational and regulatory condition of a target. In US practice, due diligence is both a contractual and a legal necessity: the scope and findings of due diligence directly inform the representations and warranties in the purchase agreement, the indemnification structure and the pricing mechanism.

Legal due diligence covers corporate organisation and authority, material contracts and their assignability, intellectual property ownership and freedom to operate, employment and benefits compliance, litigation and regulatory history, real property, environmental liability and data privacy compliance. The last category has grown substantially in importance following the California Consumer Privacy Act (CCPA) and its amendment by the California Privacy Rights Act (CPRA), as well as sector-specific federal privacy regimes. A buyer acquiring a business that processes personal data of California residents must assess compliance exposure that can translate into material post-closing liability.

Financial due diligence examines the quality of earnings, working capital normalisation, debt and debt-like items, and off-balance-sheet obligations. In private transactions, the absence of audited financials is common for smaller targets, and buyers must rely on management accounts and tax returns. A common mistake by international buyers is to treat US GAAP financial statements as equivalent to IFRS without adjustment. Material differences in revenue recognition, lease accounting and goodwill treatment can affect valuation and post-closing earn-out calculations.

Tax due diligence deserves separate attention. The US tax system imposes significant obligations on both buyers and sellers. Section 1060 of the IRC governs the allocation of purchase price in asset acquisitions across asset classes, with direct tax consequences for both parties. In share deals, the buyer inherits the target's tax history, including any unresolved IRS audit exposure, transfer pricing positions and state and local tax obligations. Many international acquirers underappreciate the complexity of US state and local tax (SALT) compliance, which varies by state and can include income tax, franchise tax, sales and use tax, and gross receipts tax.

Intellectual property due diligence is critical in technology, pharmaceutical and consumer brand transactions. The buyer must verify chain of title for patents, trademarks and copyrights, confirm that employee invention assignment agreements are in place under applicable state law, and assess freedom-to-operate risk. The America Invents Act of 2011 (AIA) introduced inter partes review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB), which can invalidate patents post-closing. A patent portfolio that appears robust at signing may face PTAB challenge within months of closing.

The HSR Act filing requirement is triggered when a transaction meets both a size-of-transaction threshold and a size-of-person threshold, as adjusted periodically by the FTC. Once a filing is made, the parties must observe a waiting period - typically 30 days for standard transactions, reduced to 15 days for cash tender offers - before closing. The agencies may issue a Second Request, which extends the waiting period and requires substantial document and data production. Second Requests are resource-intensive and can delay closing by six months or more. Parties should build HSR timing into their deal schedule from the outset.

The DOJ and FTC review transactions for competitive effects under the Clayton Act Section 7, which prohibits acquisitions that may substantially lessen competition. The agencies assess market definition, concentration levels using the Herfindahl-Hirschman Index (HHI), and potential competitive harm theories including horizontal overlap, vertical foreclosure and nascent competition concerns. Remedies range from behavioural commitments to structural divestitures. A deal that requires significant divestitures may erode the strategic rationale and require renegotiation of price or structure.

CFIUS operates under a voluntary and mandatory filing regime. Mandatory declarations are required for certain foreign government-controlled investments and for acquisitions of US businesses in critical technology, critical infrastructure or sensitive personal data sectors. Voluntary notices provide a safe harbour from post-closing review. CFIUS has authority to unwind completed transactions that were not filed, and has exercised this authority in documented cases. For any foreign acquirer, CFIUS risk assessment should be conducted before signing, not after.

Sector-specific approvals add further complexity. Bank acquisitions require approval from the Federal Reserve, the OCC or the FDIC depending on the charter type, under the Bank Holding Company Act and the Bank Merger Act. Telecommunications transactions require FCC approval. Healthcare transactions involving hospital systems may require state attorney general review under charitable trust law. Insurance company acquisitions are regulated at the state level under holding company acts that require prior approval from the state insurance commissioner.

To receive a checklist on regulatory approval requirements for M&A transactions in the USA, send a request to info@vlolawfirm.com.

The definitive purchase agreement (DPA) - whether a merger agreement, stock purchase agreement (SPA) or asset purchase agreement (APA) - is the central legal document of any US M&A transaction. Its terms allocate risk between buyer and seller across the period from signing to closing and beyond.

Representations and warranties are statements of fact about the target as of signing and closing. Breaches give rise to indemnification claims. The scope of representations - their breadth, the materiality qualifiers attached, and the knowledge qualifiers limiting seller's exposure - is intensely negotiated. Sellers push for 'material adverse effect' (MAE) qualifiers and knowledge limitations; buyers push for unqualified representations on fundamental matters such as capitalisation, authority and absence of undisclosed liabilities. The definition of MAE is itself a heavily negotiated concept, and Delaware courts have interpreted it narrowly, finding that only durationally significant, company-specific deterioration qualifies.

Indemnification provisions govern the post-closing remedy for representation breaches. Key economic terms include the basket (the threshold below which claims are not payable), the cap (the maximum aggregate indemnification liability), and the survival period (the time after closing during which claims may be brought). In transactions using RWI insurance, the indemnification structure shifts: the seller's indemnification obligations are typically limited to a small percentage of deal value, with the RWI policy providing the primary recovery mechanism for the buyer. RWI premiums in the US market typically range from a low to mid percentage of the policy limit, and the underwriting process requires sharing due diligence materials with the insurer.

Conditions to closing define what must be true or occur before either party is obligated to complete the transaction. Standard conditions include accuracy of representations, compliance with covenants, receipt of required regulatory approvals, and absence of a material adverse effect. The 'hell or high water' covenant - an obligation on the buyer to take all actions necessary to obtain antitrust clearance, including divestitures - is a key negotiating point in transactions with antitrust risk. Sellers seek broad hell-or-high-water commitments; buyers resist open-ended divestiture obligations.

Termination rights and reverse break fees address the scenario where the deal does not close. A reverse break fee - payable by the buyer to the seller if the buyer fails to close for specified reasons, typically regulatory failure - has become standard in transactions with meaningful antitrust or CFIUS risk. Reverse break fees in large US transactions typically represent a meaningful percentage of deal value. The fee is intended to compensate the seller for deal disruption and to provide the buyer with a known maximum exposure for regulatory failure.

Earn-out provisions link a portion of the purchase price to post-closing performance of the target. Earn-outs are common in transactions where buyer and seller disagree on valuation, particularly in growth-stage or founder-led businesses. In practice, earn-out disputes are among the most frequent sources of post-closing M&A litigation in US courts. The drafting of earn-out metrics, the buyer's operating covenants during the earn-out period, and the dispute resolution mechanism require careful attention.

Closing a US M&A transaction is not the end of legal exposure - it is the beginning of a new phase. Post-closing disputes arise from working capital adjustments, earn-out calculations, indemnification claims and representations and warranties breaches discovered after closing.

Working capital adjustments are mechanical in concept but frequently disputed in practice. The purchase agreement defines a target working capital level, and the actual closing working capital is measured against it, with a dollar-for-dollar price adjustment. Disputes arise over accounting methodology, classification of items and the treatment of unusual or non-recurring items. Most US M&A agreements provide for an independent accountant to resolve working capital disputes, with the accountant's determination binding on the parties.

Indemnification claims must be brought within the survival period specified in the purchase agreement. Fundamental representations - such as those relating to organisation, authority and capitalisation - typically survive for longer periods, sometimes indefinitely. Ordinary representations typically survive for 12 to 24 months post-closing. A buyer who discovers a breach after the survival period has expired loses the contractual remedy, though fraud claims may survive under general principles of Delaware law. The risk of inaction is concrete: a buyer who delays investigating a suspected breach may find the survival period has lapsed before a claim is formally submitted.

Shareholder litigation is a significant feature of US public company M&A. Plaintiffs' firms routinely file suit challenging public company mergers, alleging breach of fiduciary duty by the target board, inadequate disclosure in the proxy statement, or failure to conduct a proper sale process. While many such suits settle for supplemental disclosure rather than monetary relief, they impose transaction costs and can delay closing. Delaware courts have developed doctrines - including the Corwin doctrine, which applies business judgment review to transactions approved by a fully informed, uncoerced shareholder vote - that provide some protection to well-structured transactions.

Three practical scenarios illustrate the range of post-closing risk. First, a European strategic buyer acquires a US software company via share deal, relying on seller representations regarding IP ownership. Post-closing, it emerges that a key software module was developed by a contractor without a proper assignment agreement, creating a title defect. The buyer pursues an indemnification claim, but the survival period for IP representations is 18 months and the claim is filed at month 20. The contractual remedy is lost, and the buyer must pursue a fraud theory, which requires proving the seller's knowledge. Second, a private equity fund acquires a healthcare services business and agrees to an earn-out tied to EBITDA over two years. Post-closing, the fund implements cost-cutting measures that reduce EBITDA and the earn-out payment. The seller sues, alleging breach of the buyer's covenant to operate the business in the ordinary course. The litigation is costly and the outcome uncertain. Third, a foreign sovereign wealth fund acquires a minority stake in a US data analytics company without filing a CFIUS notice. CFIUS initiates a unilateral review post-closing and ultimately requires divestiture, resulting in a forced sale at an unfavourable price and significant legal costs.

We can help build a strategy for structuring, negotiating and closing M&A transactions in the USA. Contact info@vlolawfirm.com to discuss your specific situation.

To receive a checklist on post-closing risk management for M&A transactions in the USA, send a request to info@vlolawfirm.com.

What is the most significant legal risk for a foreign buyer in a US M&A transaction?

CFIUS review is the most asymmetric risk for foreign acquirers. Unlike antitrust review, CFIUS has broad discretion, limited judicial review and the authority to unwind completed transactions. The scope of covered transactions has expanded under FIRRMA to include non-controlling minority investments in sensitive sectors. A foreign buyer should conduct a CFIUS risk assessment before signing and consider whether a voluntary filing is advisable even where a mandatory declaration is not required. Failing to engage with CFIUS proactively can result in post-closing mitigation agreements, forced divestiture or reputational damage with US regulators.

How long does a US M&A transaction typically take from signing to closing, and what drives the timeline?

For private transactions without significant regulatory complexity, the period from signing to closing typically runs from 30 to 90 days. Transactions requiring HSR filing add a minimum of 30 days for the initial waiting period, with the risk of a Second Request extending the timeline by several months. CFIUS review adds 30 days for an initial review period, extendable by 15 days, with a full investigation adding a further 45 days. Sector-specific regulatory approvals - banking, insurance, telecommunications - can extend timelines to 6 to 18 months. Parties should build realistic regulatory timelines into their deal structure, including provisions for termination rights if approvals are not obtained within a specified outside date.

When is an asset deal preferable to a share deal in the US context?

An asset deal is preferable when the target carries significant known or contingent liabilities that the buyer does not wish to assume - environmental remediation obligations, product liability claims, pension deficits or unresolved tax disputes. Asset deals are also common in distressed situations, where the buyer acquires assets through a Section 363 sale in bankruptcy, obtaining a court order that transfers assets free and clear of most claims. The trade-off is administrative complexity: contracts must be assigned, licences re-obtained and employees rehired. Where the target's value is concentrated in contracts or licences that are non-assignable without third-party consent, a share deal may be operationally superior despite the broader liability exposure.

M&A transactions in the USA demand rigorous preparation, precise documentation and active management of regulatory, contractual and litigation risk. The combination of Delaware corporate law, federal securities regulation, antitrust review and CFIUS oversight creates a framework that rewards experienced legal counsel and penalises improvisation. International buyers and sellers who treat US M&A as a straightforward commercial negotiation - without accounting for fiduciary duty standards, survival period mechanics or CFIUS jurisdiction - routinely encounter avoidable losses. A disciplined approach to deal structure, due diligence and post-closing risk management is the foundation of a successful US transaction.

Our law firm VLO Law Firm has experience supporting clients in the USA on M&A matters. We can assist with deal structuring, due diligence coordination, regulatory filing strategy, purchase agreement negotiation and post-closing dispute management. To receive a consultation, contact: info@vlolawfirm.com.